Jump to ContentJump to Main Navigation
Discovering TuberculosisA Global History, 1900 to the Present$
Users without a subscription are not able to see the full content.

Christian W. McMillen

Print publication date: 2015

Print ISBN-13: 9780300190298

Published to Yale Scholarship Online: January 2016

DOI: 10.12987/yale/9780300190298.001.0001

Show Summary Details
Page of

PRINTED FROM YALE SCHOLARSHIP ONLINE (www.yale.universitypressscholarship.com). (c) Copyright Yale University Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in YSO for personal use (for details see http://www.yale.universitypressscholarship.com/page/privacy-policy).date: 21 November 2017

Faith, Failure, and the BCG Vaccine

Faith, Failure, and the BCG Vaccine

Chapter:
(p.110) 7. Faith, Failure, and the BCG Vaccine
Source:
Discovering Tuberculosis
Author(s):

Christian W. McMillen

Publisher:
Yale University Press
DOI:10.12987/yale/9780300190298.003.0007

Despite the 80% efficacy rate found in the American Indian trial, BCG’s use elsewhere was much less effective. Many considered it useless; others, reasoning that it was cheap and had shown considerable promise, argued that there was no good reason not to use it. This chapter explores how a controversial vaccine was able to overcame all skepticism and become the most used vaccine in history. Eventually, in one of the largest field trials of any drug, the WHO tested it in south India. It was found to have 0% efficacy.

Keywords:   BCG, India, World Health Organization

Yale Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.